Publications

Peer Review:

  1. Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R. Castration-Induced Apoptosis in the Rat Penis. Surgical Forum 1992; 48: 724-725.
  2. Te AE, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R. Neurotrophic Factors in the Diabetic Rat Penis. Surgical Forum 1993: 49: 758-760.
  3. Kaplan SA, Te AE & Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with " chronic n-bacterial " prostatitis and the therapeutic role of the endoscopic incision of the bladder neck. J Urol. 1995; 152:2063-2065.
  4. Te AE, Santarosa R, Buttyan R, Greene L, Koo HP, Kaplan SA, Olsson CA & Shabsigh R. Neurotrophic Factors in the Rat Penis. J Urol.1994; 152:2167-2172.
  5. Kaplan SA, Te AE. , Blaivas JG: Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995; 153:342-344.
  6. Kaplan SA, Te AE. Transurethral Electrovaporization of the Prostate (TVP): A novel method of treating men with benign prostatic hyperplasia. Urology 1995; 45: 566-573.
  7. Kaplan SA, Te AE. A comparative study of transurethral resection of the prostate using a modified electrovaporizaing loop and transurethral laser vaporization of the prostate. J. Urol. 1995; 154: 1785-90.
  8. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index (TZI): A novel method of assessing benign prostatic hyperplasia: correlation with symptoms, uroflow and detrusor pressure. J Urol. 1995; 154: 1764-69.
  9. Bowers DL, Te A, Hibshoosh H, Sawczuk IS Renal hemangiopericytoma. Case report and review of the literature. Urol Int 1995;55(3):162-6
  10. Kaplan SA, Bowers DA, Te AE, Olsson CA: Differential diagnosis of prostatism: 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J Urol. 1996; 155: 1305-1308.
  11. Kaplan SA, Olsson CA & Te AE: The American Urological Association symptom score in the evaluation of men with lower urinary tract symptom: At 2 years of followup, does it work?. J Urol. 155:1971-1974, 1996.
  12. Kaplan SA, Ikeguchi EF, Santarosa RP, Meade D' Alisera P, Hendriks J, Te AE & Miller MI: Etiology of voiding dysfunction in men less than 50 years of age. Urology. 47: 836-839, 1996.
  13. Kaplan SA, Santarosa RP & Te AE: Comparison of fascial and vaginal wall slings in the management of intrinsic sphincter deficiency. Urology. 47: 885-889, 1996.
  14. McKiernan JM, Kaplan SA, Santarosa RP, Te AE, Sawczuk IS: Transurethral vaporization of bladder cancer. Urology 48(2): 207-10
  15. Te AE, Santarosa R, Kaplan SA.:Electrovaporization of the prostate: electosurgical modification of standard resection in 93 patients with benign hyperplasia. J Endourol 11(1):71-5, 1997.
  16. Kaplan SA, Santarosa RP, Te AE: Transurethral electrovaporization of the prostate: one year experience. Urology 48(6):876-81, 1996.
  17. Kaplan SA, Santarosa RP, D' Alisera PM, Fay BJ, Ikeguchi EF, Hendricks J, Te, AE: Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 157(6):2234-7, 1997
  18. Kaplan SA, Reis RB, Cologna A, Suaid HJ, Martins ACP, Kohn IJ, Te AE: Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms. Urology 52(1):12-16, 1998.
  19. Kaplan SA, Te AE, Ikeguchi E, Santarosa RP: Safety and efficacy of alpha blockers in the treatment of men over the age of 80 with benign prostatic hyperplasia. Br J Urol 1997 Dec;80(6):875-9
  20. Kaplan SA, Reis RB, Staiman VB, Te AE: Is the ratio of transition zone to total prostate volume higher in African-American men than in their Caucasian or Hispanic Counterparts?. Br J Urol 1998, 82: 804-807
  21. Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, Martins ACP: Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999, 53:481-486.
  22. Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE: Combination therapy using oral alpha blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998, 52(5): 739-43.
  23. Kaplan SA, Laor E, Fatal M, Te AE: Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: a blinded, prospective comparative study with 1 years followup. J Urology 1998, 159(2):454-8.
  24. Reis RB, Te AE, Cologna AJ, Suaid HJ, Kaplan SA: Interstitial Thermometry in Men Undergoing Electrovaporization of the Prostate. J Endourology 1999, 13 (1): 53-56.
  25. Kaplan SA, Stifelman M, Avillo C, Reis RB and Te AE: Detrusor contraction duration (DCD) may predict response to alpha blocker therapy for lower urinary tract symptoms. Eur Urol 2000 Mar;37(3):314-7.
  26. Kaplan SA, Te AE, Young GPH, Andrade A, Cabelin MA, Ikeguchi EF: Prospective analysis of 373 consecutive women with stress urinary incontinence treated with a vaginal wall sling: the Columbia- Cornell university experience, J Urol. 2000 Nov;164(5):1623-7.
Non-Peer Review Publications:
  1. Kaplan SA, Te AE: Uroflowmetry & Urodynamics.Urologic Clinics of North America 1995; 22: 309-20.
  2. Te AE , Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A electrosurgical advancement of the standard TURP. Current Surgical Techniques in Urology 1995; 8:1-9.
  3. Te AE , Reis R, Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A novel modification of the standard TURP. Contemporary Urology 1995; 7:74-83.
  4. Te AE, Kaplan SA: Electrovaporization of the Prostate. Current Opinion in Urology 1996; 6: 2-9.
  5. Santarosa RP, Te AE, Kaplan SA: Minimally Invasive Procedures for Benign Prostatic Hyperplasia. Mediguide to Urology 1996; 9:1-6
  6. Te AE, Kaplan SA: Transurethral electrovaporization of the Prostate.Mayo Clin Proc 1998 Jul;73(7):691-5
  7. Te AE and Kaplan SA: Transurethral electrovaporization of the prostate: the year in review. Current Opinion in Urology 1997; 7:25-36.
  8. Santarosa RP, Te AE and Kaplan SA: Minimally invasive procedures for benign prostatic hyperplasia: electrovaporization, lasers, heat therapy and stents. In: Mediguide for Urology. Ed: Carson CC. 1996; 9:1-6.
  9. Choi J, Ikeguchi EF, Te AE, Kaplan SA: Review of laser prostatectomy. Urology Review, July, 1999.
  10. Cabelin MC, Te AE, Kaplan SA: Benign prostatic hyperplasia: challenges for the new millennium. Curr Opin Urol. 2000 Jul;10(4):301-6.
  11. Cabelin MC, Te AE, Kaplan SA: Transurethral vaporization of the prostate: Current Techniques. Current Urology Reports July 2000 1(2):116-123.
  12. Kohn I, Te AE, Kaplan SA: Neuromodulations. AUA Updates 2000; In press.
Book Chapters:
  1. Kaplan SA, Te AE: Bladder Dysfunction in Diabetes, In: Paulson, ed. Problems in Urology; Neurourology and its Role in Urologic Diseases: Part I. Philadephia: J. B. Lippincott Co., 6: 659-668. 1992.
  2. Te AE , Kaplan SA: Pharmaceutical Treatment of BPH and its effect on indications for prostate surgery. In: Surgical Technology International III: Endourology. San Francisco: Universal Medical Press, Inc.1994.
  3. Te AE, Kaplan SA: Urodynamics and BPH. In: Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis Medical Media, LTD., 187-198. 1996.
  4. Te AE, Kaplan SA: Prostatic Endoprosthetics. In: Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis Medical Media, LTD. 453-462.1996.
  5. Te AE, Kaplan SA: Electrovaporization Principles. In: Narayan P, ed. Benign Prostatic Hyperplasia. London: Churchill Livingstone, 325-334. 2000.
  6. Te AE, Kaplan SA: Electrovaporization of the Prostate: Advance Application of Electrosurgical Principles to the Treatment of Benign Prostatic Hyperplasia. In: Kirby RS, O'Leary MP, ed. Recent Advances in Urology 7. London: Churchill Livingston, 1998.
  7. Te AE, Kaplan SA: Complication of Minimally Invasive Surgery for BPH. In: Taneja SS, Smith RB, Ehrlich RM, ed. Complication of Urologic Surgery, 3rd edition. Philadelphia: W. B. Saunders, 2000.
  8. Santarosa RP, Te AE, Kaplan SA: Transurethral resection, incision and ablation of the prostate. In: Graham SD, ed. Glenn's Urologic Surgery, 5th edition. Philadephia: Lippincott, Williams and Wilkins. 921-931.1998.
  9. Te AE, Santarosa RP, Kaplan SA: Tranurethral Electrovaporization of the Prostate. In: Resnick MI, Thompson IM, ed. Surgery of the Prostate. London: Churchill Livingston.295-307. 1998.
  10. Kohn IJ, Te AE and Kaplan SA: Urodynamics of prostatitis. In: Nickel JC ed., Textbook of prostatitis. Oxford: Isis Medical Media, LTD. 2000.
  11. Te AE, Ikeguchi EF, Choi J, Kaplan SA: Urodynamics and benign prostatic hyperplasia. In: Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P., ed. Textbook of benign prostatic hyperplasia. 2nd Edition. Oxford: Isis Medical Media Ltd. In press.
  12. Cabelin M, Te AE and Kaplan SA: Urogenital physiology. In: Downey and Leiberman, ed., Rehabilitation Medicine. In press.
  13. Te AE: Indications, methods, and long term results of electrovaporization. In: Bush I., ed. Transurethral Electovaporization of the Prostate and Bladder. In press.
  14. Ikeguchi EF, Te AE, Choi J, Kaplan SA: Bladder Outlet Obstruction in Males. In: Appel RA,ed. Current Clinical Urology: Diagnosis and Treatment. Totowa, NJ: Humana Press Inc. 2000.
  15. Te AE, Ikeguchi EF, Kaplan SA: Transurethral Electrovaporization of the Prostate. In: Recent Advances in Endourology. Vol. 2/ Treatment of BPH. Tokyo: Springer-Verlag. In press.
  16. Te AE, Kaplan SA: Electrovaporization of the Prostate. In: Kaplan SA, ed. Benign Prostatic Hyperplasia: Laser and Heat Therapy.. London: Martin Dunitz. 2000.
  17. Volpe M, Ghafar MA, Te AE: Diagnosis and Management of Obstruction after Anti-Incontinence Surgery. In: Carlin BI and Leong FC, ed. Female Pelvic Health and Reconstructive Surgery. New York, NY: Marcel Dekker, Inc. In press.
Abstracts:
  1. Te AE, Buttyan R, Koo HP, Greene LA, Kaplan SA, Olsson CA & Shabsigh R: Abundant expression of nerve growth factor (NGF) in the rat penis, a developmental study. J Urol. 147:239A, 1992.
  2. Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factor in diabetic cystopathy. J Urol. 147:350A, 1992.
  3. Koo HP, Buttyan R, Te AE, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophin expression in diabetic rat penis: a new insight into pathogenesis of erectile dysfunction. J Urol. 147:240A, 1992.
  4. Shabsigh R, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Te AE: Expression of neurotrophins: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) in the rat penis. J Urol. 147:318A, 1992.
  5. Brown W, Te AE, Olsson CA & Benson MC: Management of complications of continent urinary diversions. J Urol. 147:390A, 1992.
  6. Te AE, Buttyan R, Koo HP, Olsson CA & Kaplan SA: Nerve growth factors in diabetic cystopathy. Neurourology and Urodynamics. 11(4):303, 1992.
  7. Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factors in diabetic cytopathy. Diabetes. 41(Sup 1):140A, 1992.
  8. Kaplan SA, Te AE & Blaivas JG: Urodynamic findings in patients with diabetes and voiding symptoms: surprising results. International Continence Society. 22nd Ann. Mtg. Abstract 115, 1992.
  9. Te AE, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophic Factors in the diabetic rat penis: an extended study. J Urol. 149:247A, 1993.
  10. Santarosa RP, Te AE, Koo HP, Buttyan R, Kaplan SA, Olsson CA & Shabsigh R: Androgen Deprivation and Apoptosis in Rat Erectile Tissue. J Urol. 151:494A, 1994.
  11. Te AE, Olsson CA & Kaplan SA: Use of the AUA-BPH treatment guidelines in men with symptomatic benign prostatic hyperplasia (BPH): At one year, is it effective?. J Urol. 151:507A, 1994.
  12. Shabsigh R, Te AE, Koo HP, Kaplan SA, Olsson CA & Shabsigh: Localization of nerve growth factor beta (NGF) in the rat penis by in-situ hybridization. Society for Basic Urologic Research Fall Symposium, Rochester, MN, 1991.
  13. Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA & Shabigh R: Castration- induced apoptosis in the rat penis. ACS Annual Mtg. Chicago Il, 1992.
  14. Shabsigh R, Te AE & Fisch H: Cavernous electromyography as an indication of adequate smooth muscle relaxation during duplex ultrasonography. 5th World Meeting on Impotence. Milan, Italy, 1992.
  15. Te AE, Buttyan R, Koo HP, Greene L, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophins in the rat penis. 5th World Meeting on Impotence. Milan, Italy, 1992.
  16. Santarosa RP, Te AE, Koo HP, Raymond J, Columbel M, Olsson CA, Buttyan R & Shabsigh R: Testoterone sensitivity of the erectile tissue of the rat penis to castration. 7th World Meeting on Impotence. Singapore, ISIR, 1994.
  17. Te AE, Kaplan SA, Dann JA. Transurethral electrovaporization of the prostate (TVP): A novel method for treating men with benign prostatic hyperplasia. J Urol. 1995; 153: 436A.
  18. Te AE, Santarosa R, Kaplan SA. Transurethral electrovaporization of prostate (TVP): A modification on the standard TURP. J Endourology 1995; 9: S58.
  19. Kaplan SA, Santarosa RP, Te AE: Electrovaporization of the prostate for symptomatic benign prostatic hyperplasia: the 1 year experience. J Urol. 1996, 155(5):405A.
  20. Reis RB, Cologna AJ, Suaid HJ, Kaplan SA, Te AE: Electrovaporzation of the prostate (VAP): a comparison of roller electrode configurations for resecting prostate tissue. J Urol. 1996, 155(5):406A.
  21. Laor E, Kaplan SA, Te AE, Tolia BM and Reid RE: Laser vaporization of 'large" prostate glands: long term follow - up. J Urol. 1996, 155(5):706A.
  22. Reis RB, Cologna AJ, Suaid HJ, Te AE and Kaplan SA: Interstitial thermometry in men undergoing electrovaporization: is it safe? J Urol. 1996, 155(5):707A.
  23. Kaplan SA, Santarosa RP, Te AE: The incidence of hypertension in men with benign prostatic hyperplasia. XIIth European Urology Association, Paris, 1996.
  24. Kaplan SA, Laor E, Te AE: Transurethral rsection of the prostate (TURP) versus electrovaporization of the prostate (VAP): a prospective, blinded comparative study of the treatment of benign prostatic hyperplasia (BPH). XXIIth European Urology Association, Paris, 1996.
  25. Avillo C, Stifelman M, Te AE, Sandler P and Kaplan SA: The urodynamic parameter: detrusor contraction duration (DCD) predicts response to alpha blocker therapy for lower urinary tract symptoms (LUTS). J Urol.1997, 157(4): 136.
  26. Te AE, Laor EL, Kaplan SA, Babayan R, Noble M, Mbust W, Bruskewitz R, Whitfield HN: Transurethral resection of the prostate (TURP) versus vaporization of the prostate utilizing a vaporizing loop (TVLOOP): a multicenter, blinded, prospectie comparative study. J Urol.1997, 157(4): 313.
  27. Te AE, Laor E, and Kaplan SA: Transurethral resection of the prostate (TURP) versus transurethral electrovaporization of the prostate (TVP): a blinded, prospective comparative study with 1 year follow - up. J Urol.1997, 157(4): 313.
  28. Pressler LB, Santarosa RP, Te AE and Kaplan SA: The incidence of hypertension (HTN) in a population of men with benign prostatic hyperplasia (BPH): analysis based on the AUA symptom score and race. J Urol.1997, 157(4): 371.
  29. D'Alisera PM, Stifelman M, Kohn I, Te AE, Weiner DM, Kaplan SA: Correlation of lower urinary tract symptom (LUTS) severity by International Prostate Symptom Score (IPSS) and erectile dysfunction (ED) in men over 50 years of age. J Urol. 1998, 159(5): 103.
  30. Reis RB, Suaid HJ, Cologna AJ, Te AE, Kaplan SA: Men with lower urinary tract symptoms (LUTS) and inguinal hernias (HERN) have significantly greater bladder outlet obstruction (BOO) than men with LUTS alone. J Urol. 1998, 159(5): 139.
  31. Reis RB, Suaid HJ, Cologna A, Martins ACP, Te AE, Kaplan SA: Intermittent therapy with alpha blocker, alfuzosin. J Urol. 1998, 159(5): 331.
  32. Nejat RJ, Ikeguchi EF, Te AE, Reis RB, Kaplan SA: Electrovaporization of the prostate utilizing the roller ball and/or vaporizing loop for the symptomatic benign prostatic hyperplasia (BPH): The 4- year Columbia experience. J Urol 1999, 161(4): 391.
  33. Ries RB, Martins ACP, Cologna A, Junior ST, Te AE, Kaplan SA: Long term durability of intermittent alpha blockade in the treatment of lower urinary tract symptoms (LUTS). J Urol 2000, 163(4): 1362.
  34. Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA: Characterization of lower urinary tract symptoms and prostate parameters in Asian men compared to Caucasians, Hispanics and African - Americans. J Urol 2000, 163(4): 1110, 250.
  35. Cabelin MA, Te AE, Ikeguchi EF, Andrade AJ, Young GPH, Kaplan SA: Prospective analysis of 327 women with stress urinary incontinence treated with vaginal wall sling: a multicenter experience. Neurourology & Urodynamics 2000, 19(3):323-364.
  36. Cabelin MA, Hyun G, Te AE, Meade D'Alisera P, Shabsigh R, Kaplan SA. Increased incidence of depressive symptoms in women with stress urinary incontinence. Neurourology & Urodynamics 2000, 19(3):323-364.
Video Presentations and Publications:
  1. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. J Urol.1995; 153: 48A.
  2. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Video Urology Times. 1995.
  3. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting. 1996
  4. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting. 1997
Multimedia Publications:
  1. 1. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Endourology on CD-ROM. Vol. 1, Editors; Paoletti P & Benelli R, IPE Mutimedia, Firenze, Italty.1997.

Back to topBack To Top